Clinical Trial

Effectiveness of a multicOmpoNent Behavioural intervenTion to Reduce endocrINe disrUptor Exposure During pErinatal Period (CONTINUE)

Study acronym: CONTINUE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 26, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
The general objective of HYPIEND is to understand the effects of chemical substances called "endocrine disruptors" (EDCs) during the perinatal and pre-pubertal stages. EDCs co-exposure may affect the function of hormones and determine endocrine consequences in vulnerable populations. The primary objective of this clinical study is to demonstrate that a multicomponent intervention implemented in health care centres from three European countries is effective in reducing the levels of EDCs in different body fluids of pregnant women, breastfeeding and formula feeding women as well as in their infants up to 18 months of age, improving at the same time the level of HAPA constructs (psychological determinants of behaviour) and the knowledge about these chemicals at family level.
Trial Details
NCT Number NCT07142447
Lead Sponsor Fundació Institut Germans Trias i Pujol
Collaborators: KU Leuven, Universidad de Granada, Fundació Eurecat
Conditions Pregnancy, Children
Enrollment 810 participants
Start Date 2025-02-24
Primary Completion 2026-01 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2025-08-26